1. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma
   Qian Chen et al, 2016, Oncotarget CrossRef
2. EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
   Ivana Samaržija et al, 2022, Cancers CrossRef
3. Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
   Si Sun et al, 2018, Cancer Science CrossRef
4. Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
   Bayley A. Jones et al, 2018, Molecular Cancer Therapeutics CrossRef
5. Phenotypic and Differential Gene Expression Analyses of Phase Transition in Oedaleus Asiaticus under High-Density Population Stress
   Na Guo et al, 2022, Insects CrossRef
6. Low-dose fractionated radiation reverses cisplatin resistance in ovarian cancer cells via PI3K/AKT/GSK-3β signaling
   Xiangmin Jia et al, 2017, Oncology and Translational Medicine CrossRef